DVAX vs EIX · rev $277.2M vs P/E 7.3, rev $17.60B
Dynavax Technologies Corporation (DVAX) versus Edison International (EIX) — a side-by-side from cached financials, not a winner call.
Dynavax Technologies Corporation (DVAX) is a drug manufacturers - specialty & generic company listed on NASDAQ.
Edison International (EIX) is a utilities - regulated electric company listed on US.
Latest reported DVAX revenue for 2024-12-31 was $277.2M. Net income was $27.3M. Revenue was up 19.4% from 2023-12-31 to 2024-12-31. DVAX currently screens at market cap $1.82B.
Latest reported EIX revenue for 2024-12-31 was $17.60B. Net income was $1.55B. Revenue was up 7.7% from 2023-12-31 to 2024-12-31. EIX currently screens at market cap $19.73B and trailing P/E 7.3.
DVAX currently screens at market cap $1.82B. EIX currently screens at market cap $19.73B and trailing P/E 7.3.
Not investment advice. Open the DVAX and EIX stock pages for the full models.
Not investment advice.